Next week, I am scheduled to have my prostate measured to decide on the best procedure. I have been taking 0.4 mg of ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a scope, then told ...

Tarsus Pharmaceuticals sees growth with Xdemvy's $180M sales in 2024. Read this article to know what makes TARS stock a BUY for growth investors.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

During her four-year tenure at Tarsus, Maáza Martin has spearheaded marketing and strategic planning efforts for XDEMVY, ...